Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine Maintenance vs Observation in Advanced Gastric Cancer (CMCGA1)
NCT02289547Phase 3Unknown
- Sponsor
- The Catholic University of Korea
- Start
- May 2015
- Primary completion
- Jan 2018
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in gastric adenocarcinoma, sponsored by The Catholic University of Korea. Status: unknown.
02
Drugs
capecitabine
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02289547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289547.